Evidence
J Psychopharmacol. 2024 Mar 17:2698811241239596. doi: 10.1177/02698811241239596. Online ahead of print.
ABSTRACT
As Faculty of the British Association for Psychopharmacology course on child and adolescent psychopharmacology, we present here what we deem are the most common pitfalls, and how to avoid them, in child and adolescent psychopharmacology. In this paper, we specifically addressed common pitfalls in the pharmacological treatment of autism and intellectual disability, eating disorders, neuropsychiatric correlates of epilepsy, and psychosis. Pitfalls in relation to the treatment of other disorders are addressed in a separate paper (Part I).
PMID:38494873 | DOI:10.1177/02698811241239596
Add to Google Keep
Post to X
Share on Linkedin
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II
🌐 90 Days
VR Related Evidence Matrix
Evidence Blueprint
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II
🌐 365 Days
VR Related Evidence Matrix
